BackDNA Print Genomics Overview

DNA Print Genomics Total Revenue

DNA Print Genomics's total revenue is $1.9M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$227562.00
65.08% YoY

As of Sep 2007

Annual Revenue (TTM)

$1.93M
15.16% YoY

Trailing 12 months ending Sep 2007

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

DNA Print Genomics (DNAG) FAQ

DNA Print Genomics (DNAG) currently reports a total revenue of $1.9M as of September 2007. That compares with $2.3M in the prior-year period — down 15.2% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore DNA Print Genomics's total revenue history and peer comparisons.

DNA Print Genomics's total revenue decreased from $2.3M to $1.9M — a 15.2% year-over-year decrease (period ending September 2007). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DNA Print Genomics's total revenue of $1.9M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

DNA Print Genomics reported $1.9M in total revenue as of September 2007. That compares with $2.3M in the prior-year period — down 15.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for DNA Print Genomics, and consider following DNAG for alerts when major investors trade the stock.